Hypertrophic herpes simplex virus 2 infection resistant to acyclovir in an immunosuppressed patient
Canadian Medical Association Journal · 2023
DOI: 10.1503/cmaj.221481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Medical Association Journal, 2023. Verfasst von Charlie Tan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases (Tan, Billick, Gold) and of General Internal Medicine (Gold), University of Toronto, Toronto, Ont. charlie.tan@medpor…. Hauptthemen laut MEDLINE: Acyclovir, Herpes Simplex. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases (Tan, Billick, Gold) and of General Internal Medicine (Gold), University of Toronto, Toronto, Ont. charlie.tan@medportal.ca.
- Division of Infectious Diseases (Tan, Billick, Gold) and of General Internal Medicine (Gold), University of Toronto, Toronto, Ont.
Zitieren
APA
Tan, C., Billick, M. J., & Gold, W. L. (2023). Hypertrophic herpes simplex virus 2 infection resistant to acyclovir in an immunosuppressed patient. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.221481
Vancouver
Tan C, Billick MJ, Gold WL. Hypertrophic herpes simplex virus 2 infection resistant to acyclovir in an immunosuppressed patient. Canadian Medical Association Journal. 2023. doi:10.1503/cmaj.221481
BibTeX
@article{Tan2023,
author = {Tan, Charlie and Billick, Maxime J and Gold, Wayne L},
title = {Hypertrophic herpes simplex virus 2 infection resistant to acyclovir in an immunosuppressed patient},
journal = {Canadian Medical Association Journal},
year = {2023},
doi = {10.1503/cmaj.221481}
}
EUVIMED